Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Rodman David Malcom sold 20,406 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Apr 13 to Apr 15, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 15, 2026, Rodman David Malcom (Chief Medical Officer) sold 20,406 Mineralys Therapeutics, Inc. shares at an average US$26.89 for US$549K under a trading plan, leaving 69,792 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 20,406 shares
- Price
- US$26.89 average (US$26.54 to US$27.66)
- Value
- US$549K
- Holding after
- 69,792 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Option exercise | 6,349 | US$1.08 | 82,489 | Direct |
| Apr 13, 2026 | Common Stock | Option exercise | 3,542 | US$10.20 | 86,031 | Direct |
| Apr 13, 2026 | Common Stock | Option exercise | 4,167 | US$14.25 | 90,198 | Direct |
| Apr 13, 2026 | Common Stock | Sale | 14,058 | US$26.54 | 76,140 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 6,348 | US$27.66 | 69,792 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Rodman David Malcom
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Rodman David Malcom · Aug 12, 2026
- Form 4 · Rodman David Malcom · Jul 20, 2026
- Form 4 · Rodman David Malcom · Jul 15, 2026
- Form 4 · Rodman David Malcom · Jul 10, 2026
- Form 4 · Rodman David Malcom · Jun 17, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026